Furthermore, nearly 40% of OS cell lines are ALT‐positive,19 which are resistant to most chemotherapy, and anti‐cancer therapeutics targeting ALT are not yet available, adding extra challenges to OS treatment in the clinic.9 This evidence concerns the gene GPT and cancer.